Keywords: Teva, Quartette, Oal contraceptive, USA, NDA, FDA, Bleeding

US FDA accepts Teva's Quartette NDA

Article | 13 August 2012

Print This

The US Food and Drug Administration has accepted for filing the New Drug Application for Quartette (levonorgestrel/ethinyl estradiol tablets ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in